Pfizer Says Early Data Signals COVID-19 Vaccine Is Effective
Featured Coverage of this Story
From the RightPfizer Says Early Data Signals COVID-19 Vaccine Is Effective
Pfizer announced Monday that a COVID-19 vaccine developed with its partner, BioNTech, has proved to be more than 90% effective and that it plans to ask regulators for permission to sell the shot before the end of this month if pending data shows it is safe.
"Hopefully now we can move on and get this vaccine out there and make sure it’s doing what it’s supposed to do and stop” the virus, said Kathrin Jansen, Pfizer’s head of vaccine research and development, reports The Wall Street Journal.
From the LeftPfizer Says Experimental COVID-19 Vaccine Is More Than 90% Effective
Pfizer's experimental COVID-19 vaccine appears to be working. The vaccine was found to be more than 90% effective, according to clinical results released by the company Monday.
That news comes from an interim analysis of a study involving 43,538 volunteers, 42% of whom had "diverse backgrounds."
Each participant got two injections spaced 21 days apart. The analysis compared the number of cases of COVID-19 among the volunteers getting the vaccine, with an approximately equal sized group of volunteers who got an injection of a liquid that didn't contain the vaccine....
From the LeftPfizer says early analysis shows its Covid-19 vaccine is 90% effective
Drugmaker Pfizer said Monday an early look at data from its coronavirus vaccine shows it is more than 90% effective -- a much better than expected efficacy if the trend continues.
The so-called interim analysis looked at the first 94 confirmed cases of Covid-19 among the more than 43,000 volunteers who got either two doses of the vaccine or a placebo. It found that fewer than 10% of infections were in participants who had been given the vaccine. More than 90% of the cases were in people who had been...
March 31st, 2023
March 31st, 2023
March 30th, 2023